@kmartfit's weekly testosterone shot advice, fact-checked

What did @kmartfit actually say?

@kmartfit's argument is simple: testosterone cypionate has an "eight-day half-life," so injecting once a week means your levels peak around day four and then "start to crash" by day five. The fix, according to them, is injecting "twice a week, period." No caveats, no nuance, just a blanket rule for everyone on TRT.

The advice isn't fringe. Split-dosing testosterone is genuinely common practice in clinical TRT circles, and the reasoning they gave tracks with basic pharmacokinetics. But the way they framed it, as an absolute rule with a specific crash timeline, deserves a closer look.

Does the science back this up?

Partially, yes. The half-life claim is roughly correct, and the logic about level fluctuations is real. But the specific "day four peak, day five crash" timeline is oversimplified and not supported by pharmacokinetic data as a universal experience.

Testosterone cypionate's half-life is typically cited between 7 and 8 days (Behre et al., 1999, Clinical Endocrinology). The peak serum concentration after a single injection generally occurs around 24 to 72 hours post-injection, not day four, according to FDA prescribing data for Depo-Testosterone. By day seven to eight, levels have dropped to roughly 50% of peak. So the broad arc of their argument holds: levels do fall meaningfully before the next weekly injection. But symptom timing varies considerably between individuals based on SHBG levels, metabolic rate, injection volume, and baseline testosterone. A study by Zitzmann et al. (2006, Journal of Clinical Endocrinology and Metabolism) found significant inter-individual variability in testosterone kinetics after injection, meaning "day five crash" is not a universal biological event.

What did they get wrong (or right)?

They got the core pharmacology directionally right. Weekly injections do produce more pronounced peaks and troughs than twice-weekly injections, and some patients genuinely do feel worse in the back half of their injection cycle. That's a documented clinical reality.

What they got wrong is the certainty. Saying "do not inject once a week" as an absolute ignores that some patients tolerate weekly injections well, particularly those with lower SHBG or who use smaller doses. There is also a legitimate case for less frequent injections in certain protocols. The claim that symptoms "start to crash" on a predictable day-five schedule treats every patient's endocrine system identically, which no endocrinologist would do. Research from Snyder et al. (2000, Annals of Internal Medicine) showed that symptom response to testosterone therapy varies widely based on individual physiology, comorbidities, and baseline hormone status. The "period" at the end of their sentence is doing a lot of work that the evidence doesn't fully support.

What should you actually know?

If you're on TRT and feeling worse in the second half of your weekly injection cycle, splitting your dose into two smaller twice-weekly injections is a reasonable thing to discuss with your prescriber. Many clinicians do prefer this approach for exactly the reasons @kmartfit described: more stable serum levels, fewer symptom fluctuations, and a smoother hormonal environment.

But injection frequency is a clinical decision, not a TikTok rule. Factors like your SHBG level, hematocrit, injection tolerance, and lifestyle all matter. Some patients on once-weekly protocols have stable, symptom-free results. Others do better on twice-weekly or even subcutaneous micro-dosing. A 2021 review by Ramasamy et al. (Translational Andrology and Urology) noted that no single injection protocol is universally optimal, and individualized dosing guided by lab monitoring remains the standard of care.

If you're experiencing cyclical low-T symptoms mid-week, bring your symptom log and trough lab values to your provider. That conversation is more useful than any TikTok video, including this one.